CIK 0001501989 · Accelerated filer
CytomX Therapeutics, Inc.
Sign in to watch- Ticker
- CTMX
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 273521219
- Phone
- 650.515.3185
- Business address
- 151 OYSTER POINT BLVD., SUITE 400, SOUTH SAN FRANCISCO, CA, 94080
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2017-06-05 | McCarthy Sean A. President and CEO | Sale | −300 | $15.00 | $5K | 4,245 |
| 2017-06-05 | McCarthy Sean A. President and CEO | Option exercise · Stock Option (right to buy) | −300 | 67,772 | ||
| 2017-05-31 | McCarthy Sean A. President and CEO | Grant or award | +2,266 | $8.68 | $20K | 4,245 |
| 2017-05-31 | RAY DEBANJAN Chief Financial Officer | Grant or award | +2,698 | $8.68 | $23K | 24,626 |
| 2017-05-12 | Goeltz II Robert C. Chief Financial Officer | Option exercise | +9,980 | $4.47 | $45K | 22,769 |
| 2017-05-12 | Goeltz II Robert C. Chief Financial Officer | Option exercise | +9,987 | $6.61 | $66K | 32,756 |
| 2017-05-12 | Goeltz II Robert C. Chief Financial Officer | Option exercise · Stock Option (Right to Buy) | −9,980 | 204,678 | ||
| 2017-05-12 | Goeltz II Robert C. Chief Financial Officer | Option exercise · Stock Option (Right to Buy) | −9,987 | 85,891 | ||
| 2017-05-01 | McCarthy Sean A. President and CEO | Option exercise | +4,781 | $0.95 | $5K | 6,760 |
| 2017-05-01 | McCarthy Sean A. President and CEO | Sale | −4,781 | $15.70 | $75K | 1,979 |
| 2017-05-01 | McCarthy Sean A. President and CEO | Option exercise · Stock Option (right to buy) | −4,781 | 68,072 | ||
| 2017-04-14 | Kavanaugh William Michael CSO, Head Res.&Non-Clin. Dev. | Grant or award · Stock Option (Right to Buy) | +48,368 | 96,736 | ||
| 2017-04-12 | STARR KEVIN P 10% owner | Sale | −28,357 | $16.36 | $464K | 31,419 |
| 2017-04-10 | Goeltz II Robert C. Chief Financial Officer | Option exercise | +3,000 | $4.47 | $13K | 12,789 |
| 2017-04-10 | Goeltz II Robert C. Chief Financial Officer | Option exercise · Stock Option (Right to Buy) | −3,000 | 214,658 | ||
| 2017-04-04 | McCarthy Sean A. President and CEO | Option exercise | +4,781 | $0.95 | $5K | 6,760 |
| 2017-04-04 | McCarthy Sean A. President and CEO | Sale | −4,781 | $17.50 | $84K | 1,979 |
| 2017-04-04 | McCarthy Sean A. President and CEO | Option exercise · Stock Option (right to buy) | −4,781 | 72,853 | ||
| 2017-04-03 | McCarthy Sean A. President and CEO | Option exercise | +4,781 | $0.95 | $5K | 6,760 |
| 2017-04-03 | McCarthy Sean A. President and CEO | Sale | −4,781 | $16.94 | $81K | 1,979 |
Page 25 of 33 · 649 trades